|
Real-time Estimate
Cboe BZX
19:30:12 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 13.28 USD | -2.60% |
|
+7.45% | +62.22% |
Company Valuation: ORIC Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 578.9 | 264.8 | 501.9 | 569.5 | 796.6 | 1,413 | - | - |
| Change | - | -54.26% | 89.55% | 13.47% | 39.89% | 77.34% | - | - |
| Enterprise Value (EV) | 578.9 | 264.8 | 266.8 | 569.5 | 751 | 1,413 | 1,413 | 1,413 |
| Change | - | -54.26% | 0.78% | 113.42% | 31.87% | 88.13% | 0% | 0% |
| P/E | -7.1x | -2.62x | -4.69x | -4.41x | -5.56x | -8.98x | -8.06x | -7.07x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | -0.3x | 0.4x | 0.66x | 0.3x | -2.77x | -0.7x | -0.5x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 512x |
| EV / Revenue | - | - | - | - | - | - | - | 512x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -8.75x | -8.53x | -9.88x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -7.89x | -6.76x | -5.94x |
| EV / FCF | -0x | -0x | -0x | -0x | -0x | -10.5x | -8.51x | -7.05x |
| FCF Yield | -10.4% | -29.2% | -17.2% | -20% | -14% | -9.52% | -11.7% | -14.2% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -2.07 | -2.25 | -1.96 | -1.83 | -1.47 | -1.518 | -1.691 | -1.927 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 2.757 |
| EBITDA 1 | -77.97 | -90.8 | -109.7 | -141.8 | -141.8 | -161.4 | -165.6 | -143 |
| EBIT 1 | -78.87 | -91.77 | -110.8 | -142.9 | -143 | -179 | -209.1 | -237.8 |
| Net income 1 | -78.72 | -89.12 | -100.7 | -127.8 | -129.5 | -166 | -199.2 | -249.4 |
| Net Debt | - | - | -235 | - | -45.67 | - | - | - |
| Reference price 2 | 14.70 | 5.89 | 9.20 | 8.07 | 8.18 | 13.63 | 13.63 | 13.63 |
| Nbr of stocks (in thousands) | 39,382 | 44,953 | 54,552 | 70,567 | 97,389 | 103,653 | - | - |
| Announcement Date | 21/03/22 | 16/03/23 | 11/03/24 | 18/02/25 | 23/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.98x | - | - | -.--% | 1.41B | |
| 18.38x | 6.48x | 12.88x | 1.62% | 63.29B | |
| 30.22x | 7.94x | 26.49x | 0.05% | 54.89B | |
| 36.58x | 6.5x | 19.41x | 0.88% | 53.28B | |
| 35.46x | 3.44x | 14.83x | -.--% | 45.81B | |
| 50.32x | 5.82x | 31.95x | -.--% | 43.46B | |
| -19.48x | 188.5x | -20.74x | -.--% | 40.23B | |
| 29.02x | 8.23x | 21.28x | 0.37% | 33.45B | |
| 27.38x | 5.77x | 14.95x | -.--% | 23.7B | |
| 32.79x | 5.99x | 20.16x | -.--% | 23.76B | |
| Average | 23.17x | 26.52x | 15.69x | 0.29% | 38.33B | |
| Weighted average by Cap. | 26.57x | 25.51x | 15.93x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORIC Stock
- Valuation ORIC Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
